KOL Management is Global, and LNX Pharma Helps You See the World's Relationships

products » Global Competitiveness

Navigating the turbulent waters to bring new pharmaceutical and medical products to market, from idea to consumer, requires insight and fortitude.  With the pace of change since the first human genome project accelerating the need to understand and adjust course swiftly is critical.  Companies have had to adopt new methods and strategies, but perhaps the biggest hurdle is changing human behavior fast enough to adapt to new patterns.  The traditional method of reaching out to your neighbors is no longer sufficient in a global market. Not surprisingly, clients intuitively react by using Key Opinion and Scientific Leaders (KOL/SLs.)  However, few but the early adopters understand that managing global communities is more than engaging a few key individuals.  As good understanding, leads to comprehension and insights.

Lnx Pharma Social Network Analysis Framework now gives companies a method to understand the complexity of human interactions and leverage groups to:

  • maximize results
  • optimize resource deployment
  • leverage relationships
  • expand into new markets
  • build brand equity faster
  • protect against disruption
  • shore up weaknesses
  • increase revenue

Lnx Pharma utilizes social network analysis to provide insights into the entire scientific community.

Lnx Pharma Key Opinion and Scientific Leader Identification and Segmentation Analysis allows clients to selectively pick KOL/SLs from the Invisible College to align with client goals.

Often clients choose the quantity of KOL/SLs based on their budget or on a limited ability to engage each KOL/SL.  However, a global community with 50,000 scientists is remarkably different than 5,000 scientists.  Lnx Pharma Invisible College allows a client to identify the sustainable quantity of KOL/SLs and more importantly calculate their reach with Reach Analysis.

KOL/SLs play an important part in education and serve as change agents to overcome resistance to new and better treatments. If through the educational process resistance and "Negative" messages occur, clients are faces with stepping up educational efforts everywhere rather than targeted treatment at the source.  With Reach Analysis and Cluster Analysis sources of "Negative" and "Contrarian" messages can be mitigated, surrounded and cut off.

Perhaps more powerful than surrounding negative messages is creating an environment of positive affirmation where "Positive" messages can be more easily sustained and hardened to prevent disruptions in communications.

Well integrated KOL/SL groups act as early warning systems, with a network of feelers and sensors deployed around the globe. They are especially important for spotting meteoric stars - profound insights and discoveries that often mean the first one there wins.

With Broker and Gateway Analysis and Cluster Analysis Lnx Pharma helps clients find adjacent markets. These markets can be viewed as opportunities for expansion or encroachments that must be mitigated.

To rapidly expand into adjacent markets Lnx Pharma Segmentation Analysis along with Broker and Gateway Analysis can identify the perfect KOL/SL to serve as a bridge between two related markets.

Having a global perspective allows marketing team through Structural Hole Analysis to identify areas or individuals with few connections needing help to establish access to more resources and information. Similarly Isolate Analysis examines groups disconnected from the main community for inclusion/exclusion.

Need something custom, have a unique situation? Lnx Pharma can extract relationships and derive meaning from nearly any data source including clinical trial data, grants, patents, web content. contact us for more information.